chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 hours later I had in my mouth a chemical taste for about 15 minutes. 7 hours after the shot I was sore at the injections site. Around 2am I started having stomach issues. I had diarrhea 7 times. I have intestinal issues and discomfort. I had taken 2 anti diarrheal pills. I finally went back to sleep. That next day I was fine. The day after I could hear gurgling in my stomach but never had any more issues. That day I felt that under my armpit my lymph nodes were tender. It was like a rollercoaster from arm, to armpit, to stomach and back again to the arm.
Patient called on 10/29/18 and said that she woke up on 10/26/18 with aches especially in her knees and a fever of 100 degrees F and also that the injection site had swelled to the size of a baseball.
Passed out on May 1 2021 admitted into hospital with saddle bag pe and dvt
was sick; flu; Initial information was received on 10-Oct-2020 regarding an unsolicited valid non-serious social media case from a consumer via social media.  This case involves patient (unknown demography) who got flu (influenza) and was sick (illness), while the patient received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious who got flu (influenza) and was sick (illness), (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the events.  There will be no information available on the batch number for this case.
Student c/o dizziness and poor focus with H1N1 shot. Monitored VS, O2 applied, controlled breathing techniques utilized. Parents notified and picked up student for transport.
raised rash with small itchy bumps, about the size of a large bandaid, on he forearm of the arm that was vaccination site.
Raised bumps and redness with itching symptoms. Started Tuesday and continuing to present with mild to medium severity. Recommend seeing PMD if it continues and report back to MDS.
Tinnitus; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced TINNITUS (Tinnitus). At the time of the report, TINNITUS (Tinnitus) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant was provided. Patient treatment information was not provided.
Patient received smallpox vaccination 9 FEB 08.  26 FEB patient was seen in ER for swelling of both hands, elbow and ears with lesions and papules.  Hibiclens ordered.
High fever, aches, chills led to inner ear infection and pink eye. Upper respiratory problems...bad cough.  This has been ongoing now for two weeks.  Vision changes on 8/21/2013 lasted a few hours.
Systemic: Allergic: Rash (specify: facial area, extremities)-Mild, Systemic: Heart Attack-Medium, Systemic: Numbness (specify: facial area, extremities)-Medium, Systemic: Tingling (specify: facial area, extremities)-Medium, Additional Details: Within 2 mins patent started to feel numbness like novocaine & tingling in left ear. left side of face & left side of mouth, ear and facial area were red & warm.
I received my 1st dose on 12FEB2021 & decided not to receive second dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I received my 1st dose on 12FEB2021 & decided not to receive second dose) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     The patient's past medical history included Rheumatoid arthritis. Concomitant products included LISINOPRIL for Blood pressure, ETANERCEPT (ENBREL) for Rheumatoid arthritis, METOPROLOL, SIMVASTATIN and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I received my 1st dose on 12FEB2021 & decided not to receive second dose). On 12-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I received my 1st dose on 12FEB2021 & decided not to receive second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Treatment information provided
Heart palpitations/heart was so erratic; Amost close to fainting; Weakness/Feeling weak; Feels like a wall hit her and it was from the vaccine.; Dizzy; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart palpitations/heart was so erratic), PRESYNCOPE (Amost close to fainting), ASTHENIA (Weakness/Feeling weak), VACCINATION COMPLICATION (Feels like a wall hit her and it was from the vaccine.) and DIZZINESS (Dizzy) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder.    On 03-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Aug-2021, the patient experienced PALPITATIONS (Heart palpitations/heart was so erratic), PRESYNCOPE (Amost close to fainting), ASTHENIA (Weakness/Feeling weak), VACCINATION COMPLICATION (Feels like a wall hit her and it was from the vaccine.) and DIZZINESS (Dizzy). At the time of the report, PALPITATIONS (Heart palpitations/heart was so erratic), PRESYNCOPE (Amost close to fainting), ASTHENIA (Weakness/Feeling weak), VACCINATION COMPLICATION (Feels like a wall hit her and it was from the vaccine.) and DIZZINESS (Dizzy) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Lab test included stress test , calcium score, echo , CT scan and also patient had to wear Holter monitor for 2 days.  Patient reports that the symptoms was pretty much resolved but it goes away and comes back. and she is nervous to receive her second dose  due to reaction from first dose.  Treatment information was not provided.
very bad dizziness; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 26Feb2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "very bad dizziness".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Irregular periods, 14 up to 45 day cycles. Severe cramping up to 10 days with no period. Changes in mood, feeling down and not like myself. Elevated lymphocyte count. Symptoms lasting more than 5 months and affecting daily activities and quality of life. Gynecologist and Immunologist consult; gynecologist recommended infertility consult.  Outcome: AE not resolved.
nflammation, pain, swelling at the injection site which was the fatty part at the back of my right arm.  Muscle pain, especially my left biceps, which I had from work out strain before the injection but which got worse after.  Feel soreness all over the body: arms, legs, fingers, where my dental crown was done.  Tiredness.  Maybe fever because I was hot when sleeping but I didn?t measure it.
FLUMIST admin 9/12/13. Rash noted 9/17/13. Seen 9/19/13 and 9/20/13. On 9/20/13 diagnosed as erythema multiforme. No known illness, no fever.
My throat felt off and I was coughing during the night. On Sunday, coughing, achy, fatigue and I felt head pressure. The next day, I had a runny nose, stuffy head, tired, achy muscles, and a low grade temperature. I felt somewhat dizzy, loss of appetite, headache, chills, and a little nausea. The next day, I had fatigue and a bad taste in my mouth. On the 15th, fatigue, bad taste, if I tilted my head, I would feel dizzy. I may have started feeling better that Friday. I did take a COVID-19 test that day and I tested positive. I took PAXLOVID starting on 02/13/2023 and started taking that that evening. I took my last PAXLOVID dose on Saturday 02/18/2023. On Sunday 02/19/2023, I tested negative. Sometime on Tuesday 02/21, I also tested negative again. Wednesday 02/22 in the morning I tested again and it was negative. In terms of tilting my head and feeling a little dizzy, that continued for about another week into the 20th up until maybe Thursday. I'm unsure of the exact timeline. I felt like it was a really mild case. My partner and I were in the same home during this infection, and luckily he did not get COVID-19.
about 3am I woke up with severe body aches- I got out of bed at 9:45am- took Extra Strength Tylenol and the aches gradually went away
Right upper arm with quarter size purple bruise at injection site. Approx 2" red, warm band below injection site. Tender to touch, pain in right armpit. (red area 12cm x 5cm). Rechecking on 10/23. Placed on antibiotics at appt on 10/20/17.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. A 51-year-old male patient received BNT162b2 (BNT162B2), on 18Oct2021 as dose 3 (booster), single (Lot number: EW0183) at the age of 51 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 24Jun2022 as dose 4 (booster), single (Lot number: 060A22A), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: PCN" (unspecified if ongoing). There were no concomitant medications. Past drug history included: Asa, reaction(s): "Known allergies"; Compozine, reaction(s): "Known allergies". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 16Jul2022, outcome "recovering" and all described as "Treatment of COVID-19". Adverse events resulted in none of the above. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results, notes: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for [BNT162B2] has been requested and will be submitted if and when received.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded.
Information has been received from a healthcare worker concerning a 18 year old female patient. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were not reported. On 28-MAR-2016 the patient was vaccinated with a dose of PROQUAD (Merck) (dose, unit and route not reported, lot # L046506 and Exp. date 17-MAY-2017) (inappropriate schedule of drug administration). No adverse effect was reported. This report is linked with 1603USA013691 (sibling and same reporter). Additional information has been requested.
Reports onset of throat swelling and difficulty swallowing which started app. 30 minutes after vaccine administered. Not reported to clinic until following day (4/8).
This spontaneous report as received from a certified medical assistant (C.M.A.) refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, concomitant medication and drug reactions or allergies was reported. On 10-JUL-2015, the patient was inadvertently administered with one dose of expired M-M-R II, (dose was not provided), lot # 1684AA, batch # J006139, expiration date 17-APR-2015. No adverse effects were reported. Additional information has been requested.
Patient received 2nd vaccine on 8/25/21. She started having moderate headaches, right eye pain with hypersensitivity to light, and nausea. She called her physician on 8/27/21 to inform him of what was going on. He ordered pain medications. Patient's pain became more intense and she went in to the see her physician on 8/31/21. She was diagnosed with Ramsey Hunter Syndrome and was referred to an optometrist. She was seen per the optometrist on 8/31/21 and he confirmed the diagnoses of Ramsey Hunter Syndrome. She was placed on Zovirax, anti-inflammatory, and pain medications.  She had follow up with the optometrist on 9/10/21 and was diagnosed with Huntchinson's Sign . She will off work for entire month of September.
Narrative:  PATIENT PASSED AWAY DUE TO COVID 19 .HE HAD RECEIVED COVID-19 VACCINE
Information has been received from a certified medical assistant concerning an 18 year old female with no medical history or allergies, who on 27-FEB-2007 at 16:30 was vaccinated IM into the right arm with a first dose of GARDASIL vaccine (lot # 656372/0243U). About 5 minutes later the patient was on the floor because she had fainted and nauseous. It was reported that she sat for a few minutes and "felt fine" and was sent home. On 30-APR-2007 at 13:30, the patient was vaccinated IM into the left arm with a second dose of GARDASIL vaccine(lot# 657622/0388U). Immediately, the patient experienced the same symptoms and became nauseous and vomited. The patient did not faint. It was reported that afterward she was better. Additional information has been requested. This is in follow-up to report (s) previously submitted on 7/16/2007. It was reported that the patient recovered in minutes. Additional information has been requested
Sore arm; This is a spontaneous report from contactable consumer (patient) via Pfizer Sales Representative. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as a dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, a patient of female 66 had a sore arm after the vaccine on an unspecified date. Stated that, the event took place after use of product. The outcome of the event was unknown.  Information about batch/lot number has been requested. Follow-up attempts are completed. No further information is expected.
SORE ARM; FATIGUE; HEADACHE; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced sore arm, fatigue, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fatigue, headache and sore arm was not reported. This report was non-serious. This case, from the same reporter is linked to 20210326425.
After I received my 2nd dose of the Pfizer vaccine I experienced cramping two weeks before my period  . This is very abnormal for me because I  only experience cramping when my cycle is about to start . I?ve also noticed changes in my period
On Wednesday, arm was itchy near injection site. It grew warm, swollen, and red. By Thursday, the affected area was growing. By Friday, symptoms were felt from the shoulder to the elbow.
Approximately 6 weeks post immunization patient experiencing rash on front and rear torso area, itching as well as nausea and vomiting. Was seen by primary care physician and per patient reaction is attributed to vaccine.
Received dose of Pediarix at 2 months and Vaxelis at 4 months; This non-serious spontaneous safety report case #02087821 and Interaction #02087770 was received from a Medical Assistant by the partner on 10-Jan-2022 and forwarded on 11-Jan-2022.  Due to the nature of the event, the causality between Vaxelis and the reported event: "the patient received a dose of Pediarix at 2 months followed by a dose of Vaxelis at 4 months" was not applicable.  Further information is expected.  FOLLOW-UP INFORMATION case #02087821 was received from a Medical Assistant by the partner on 28-Jan-2022 and forwarded on 31-Jan-2022. The case is maintained as non-serious. The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient and that the Department of Health recommended Vaxelis at the 6 month visit.  Due to the nature of the event, the causality between Vaxelis and the reported event: "the patient received a dose of Pediarix at 2 months followed by a dose of Vaxelis at 4 months" remains not applicable.  Further information is not expected.
swollen rt hand then lt hand then lt foot; foot has persisted 3 wks;
Welts; Red bumps; Rash, stomach,neck and back; fever; flu-like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu-like symptoms), URTICARIA (Welts), VACCINATION SITE ERYTHEMA (Red bumps), RASH (Rash, stomach,neck and back) and PYREXIA (fever) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DIAZEPAM, LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) and OMEPRAZOLE for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu-like symptoms) and PYREXIA (fever). On 02-Apr-2021, the patient experienced URTICARIA (Welts), VACCINATION SITE ERYTHEMA (Red bumps) and RASH (Rash, stomach,neck and back). At the time of the report, INFLUENZA LIKE ILLNESS (flu-like symptoms), URTICARIA (Welts), VACCINATION SITE ERYTHEMA (Red bumps), RASH (Rash, stomach,neck and back) and PYREXIA (fever) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
I had the moderna shot last Wednesday and yesterday my left arm started feeling hot and today it turned red in the shot area and is now spreading down my arm and now is feeling hot up my neck and ear on the left side.
Broke out in hives, face wash itchy and hot, arms were numb and tingly and cold
Covid arm; red rash size of her hand; redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Covid arm), RASH ERYTHEMATOUS (red rash size of her hand) and VACCINATION SITE ERYTHEMA (redness at injection site) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced VACCINATION SITE REACTION (Covid arm), RASH ERYTHEMATOUS (red rash size of her hand) and VACCINATION SITE ERYTHEMA (redness at injection site). At the time of the report, RASH ERYTHEMATOUS (red rash size of her hand) and VACCINATION SITE ERYTHEMA (redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
C/O Dizziness and L shoulder pain radiating to neck and occipital lobe - recovering from dizziness after 30 min. Sent home with recommends to take TYLENOL for pain and warm compress to shoulder.
Patient presents back to the COVID clinic approximately one hour post vaccine with chief complaints of total body urticaria and light headed
PATIENT HAD PFIZER VACCINE Dose 1 date:12/29/2020,  Dose 2 date: 01/19/2021, AND TESTED POSITIVE TO COVID.
Symptoms occurred several hours after receiving the flu vaccine. Symptoms included low-grade fever, facial flushing, headache, edema of lower lip and hands, chest tightness, and myalgia. Symptoms improved with administration of BENADRYL.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. On or about 06-NOV-2013, the patient was inoculated with ZOSTAVAX vaccine (Dose, route of administration, site of administration, Lot number and expiration date were not provided) at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 27-JUN-2016, the patient was treated by a physician (at a medical facility/office) for a persistent vesicular rash, which was diagnosed as herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX. The outcome of the events was unknown. Additional information has been requested.